The global interventional cardiology devices market is projected to reach USD 42.39 billion by 2031, from USD 31.12 billion in 2026, growing at a CAGR of 6.4% during the forecast period.
The worldwide interventional cardiology devices market is growing mainly because of factors such as a higher incidence of cardiovascular diseases, a preference for less invasive procedures, and an aging global population. In addition, innovations in medical technology, such as drug-eluting stents, bioresorbable scaffolds, and enhanced imaging with catheter-based techniques, are making procedures safer and more successful. Furthermore, the spread of better healthcare facilities in developing countries, the introduction of reimbursement policies that encourage treatment in developed regions, and higher consumer awareness of heart disease detection and treatment are also contributing to market growth.
“Based on the angioplasty balloon type, the old/normal balloons segment is expected to grow by the highest CAGR in the interventional cardiology devices market.”
The old or normal (plain) angioplasty balloons segment of the angioplasty balloons market is growing due to low cost, general acceptance in clinical practice, and high usage in routine and first-line percutaneous coronary interventions, especially in developing and cost-sensitive healthcare settings. They are frequently used to prepare the lesion for stent placement and in uncomplicated coronary and peripheral procedures, which helps maintain demand. Moreover, their established safety record, user-friendliness, and the wide range of available sizes make them the preferred option in high-volume hospitals, thereby contributing to the continuous growth of the market, even though there have been developments in the technologies for specialty balloons.
“The embolic protection devices segment in the hemodynamic flow alteration devices segment is expected to grow with the highest CAGR in the interventional cardiology devices market.”
Cardiovascular and neurovascular interventions, especially transcatheter aortic valve replacement (TAVR), carotid artery stenting, and peripheral vascular procedures, are the main drivers of increased sales of embolic protection devices in the hemodynamic flow alteration device market. These devices, which prevent strokes and distal ischemia that may occur as a side effect of the procedure, have led to more patients being treated and better clinical outcomes. Market growth is supported by technological advancements that yield better filters, more efficient capture, and easier deliverability, as well as by positive clinical evidence and the rising popularity of minimally invasive procedures among the elderly.
“The guidewires segment in the other devices segment is expected to grow with the highest CAGR in the interventional cardiology devices market.”
Growth in the interventional cardiology devices market's guidewires segment is primarily driven by the rising incidence of surgical interventions involving percutaneous coronary angioplasty, a direct result of the global rise in cardiovascular diseases. Guidewires are among the most essential items for interventional procedures, creating steady demand in hospitals and catheterization labs. Emerging technologies, such as improved torque control, greater flexibility, hydrophilic coatings, and enhanced lesion-crossing ability, have expanded their use in complex and chronic total occlusion procedures. In addition, the growing preference for minimally invasive treatments, expanding healthcare infrastructure in developing countries, and the large number of procedures performed in both diagnostic and therapeutic interventions continue to support the market growth.
“Based on the end user, the hospital segment is expected to grow by the highest CAGR in the interventional cardiology devices market.
Most interventional cardiology procedures, such as angioplasties, stent placements, and structural heart interventions, are performed in hospitals because they offer specialized facilities and sophisticated imaging technologies that support high-quality patient care. Hospitals are well-equipped for both simple and complex procedures. These settings enable cardiologists to apply the latest technologies, including drug-eluting stents, rotational atherectomy, and intravascular ultrasound, to ensure utmost precision and safety for patients.
“The Asia Pacific is expected to grow with the highest CAGR in the interventional cardiology devices market during the forecast period.”
The rise in cardiovascular diseases and the growing number of catheter-based heart surgeries performed in hospital settings have been the main drivers of growth in the interventional cardiology devices market. Hospitals are major end users, where complex and high-risk interventions are carried out because of their advanced infrastructure, the presence of skilled interventional cardiologists, and access to hybrid operating rooms and cath labs. The increasing use of minimally invasive techniques, favorable reimbursement for inpatient and outpatient cardiac interventions, and hospitals' ongoing investment in advanced interventional technologies also support their dominance and contribute to market growth.
The breakup of the profile of primary participants in the interventional cardiology devices market:
• By Company Type: Tier 1- 35%, Tier 2- 45%, and Tier 3-20%
• By Designation: C-level Executives- 35%, Directors- 25% , and Others- 40%.
• By Region: North America - 40%, Europe – 30%, APAC –20%, Latin America – 5%,Middle East & Africa–5%
Key players in the interventional cardiology devices market
Some of the prominent players operating in the interventional cardiology devices market include Boston Scientific Corporation (US), Medtronic (US), Abbott (US), B. Braun SE (Germany), Terumo Corporation (Japan), Edwards Lifesciences Corporation (US), Koninklijke Philips N.V. (Netherlands), Integer Holdings Corporation (US), Teleflex Incorporated (US), Penumbra, Inc. (US), Cook (US), Cordis (US), iVascular S.L.U (Spain), Biosensors International Group, Ltd (Singapore), BIOTRONIK SE & Co. KG (Germany), AMG International (Germany), ENDOCOR GmbH (Germany), InSitu Technologies, Inc. (US), Meril Life Sciences (India), Alvimedica (Istanbul), Cardionovum GmBH (Germany), Medinol Ltd (Turkey), Wellinq (Netherlands), Balton SP (Poland), Translumina (India).
Research Coverage:
The report analyzes the interventional cardiology devices market and aims to estimate the market size and future growth potential across segments such as angioplasty stents, structural heart devices, catheters, angioplasty balloons, plaque modification devices, hemodynamic flow alteration devices, other devices, and end users. The report also includes a product portfolio matrix of the interventional cardiology technologies available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will provide market leaders and new entrants in this market with the closest available estimates of revenue for the overall interventional cardiology devices market and its subsegments. It will help stakeholders understand the competitive landscape and gain insights to position their businesses more effectively and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
• Analysis of key drivers (Growing prevalence of cardiovascular diseases, Technological Advancements in interventional cardiology procedures, Increased prevalence of diabetes), restraints (Availability of alternative treatments, Recall of Products by Industry Participants to Limit the Uptake of Interventional Cardiology Equipment), opportunities (Growing Coronary Stent Demand in Developing Countries, Growing Product Launches by Leading Players in Developing Countries) challenges (Stringent regulatory requirements delaying the approval of cardiac devices)
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global interventional cardiology devices market.
• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new product launches in the global interventional cardiology devices market
• Market Development: Comprehensive information on the lucrative emerging markets by angioplasty stents, structural heart devices, catheters, angioplasty balloons, plaque modification devices, hemodynamic flow alteration devices, other devices, and end users.
• Market Diversification: Exhaustive information about new products and services or product and service enhancements, growing geographies, recent developments, and investments in the global interventional cardiology devices market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products and services, and capacities of the major competitors in the global interventional cardiology devices market.
圖表清單 List of Tables & Figures
TABLE 1 INCLUSIONS & EXCLUSIONS 38
TABLE 2 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 39
TABLE 3 DIABETES POPULATION, BY REGION, 2024 VS. 2050 53
TABLE 4 FDA MEDICAL DEVICE USER FEE STRUCTURE (MDUFA VI – FY2025) 58
TABLE 5 INTERVENTIONAL CARDIOLOGY DEVICES MARKET:
PORTER’S FIVE FORCES ANALYSIS 62
TABLE 6 GDP CHANGE, BY KEY COUNTRY, 2021–2030 (USD BILLION) 65
TABLE 7 LIST OF KEY INTERVENTIONAL CARDIOLOGY DEVICE MANUFACTURERS 71
TABLE 8 LIST OF KEY END USERS 72
TABLE 9 LIST OF KEY REGULATORY BODIES 72
TABLE 10 AVERAGE SELLING PRICE TREND OF ANGIOPLASTY STENTS, BY TYPE,
2023–2025 (USD) 73
TABLE 11 AVERAGE SELLING PRICE OF DRUG-ELUTING STENTS, BY KEY PLAYER, 2025 (USD) 74
TABLE 12 AVERAGE SELLING PRICE TREND OF CATHETERS, BY TYPE, 2023–2025 (USD) 75
TABLE 13 AVERAGE SELLING PRICE TREND OF INTERVENTIONAL CARDIOLOGY DEVICES,
BY REGION, 2023–2025 (USD) 76
TABLE 14 IMPORT DATA FOR HS CODE 9018-COMPLIANT PRODUCTS, BY COUNTRY,
2021–2025 (USD THOUSAND) 78
TABLE 15 EXPORT DATA FOR HS CODE 9018-COMPLIANT PRODUCTS, BY COUNTRY,
2021–2025 (USD THOUSAND) 78
TABLE 16 IMPORT DATA FOR HS CODE 9021-COMPLIANT PRODUCTS, BY COUNTRY,
2021–2025 (USD THOUSAND) 79
TABLE 17 EXPORT DATA FOR HS CODE 9021-COMPLIANT PRODUCTS, BY COUNTRY,
2021–2025 (USD THOUSAND) 80
TABLE 18 KEY BILLING CODES USED FOR INTERVENTIONAL
CARDIOLOGY DEVICE CATEGORIES 81
TABLE 19 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: MAJOR CONFERENCES & EVENTS, 2026–2027 82
TABLE 20 EDWARDS SAPIEN 3 ULTRA RESILIA VALVE: SEVERE AORTIC STENOSIS PATIENT 84
TABLE 21 ABBOTT MITRACLIP: SEVERE RHEUMATIC MITRAL REGURGITATION 85
TABLE 22 BOSTON SCIENTIFIC WATCHMAN FLX: STROKE PREVENTION IN HIGH BLEEDING-RISK AF PATIENT 85
TABLE 23 RECIPROCAL TARIFF RATES ADJUSTED BY US, 2025 86
TABLE 24 KEY PRODUCT-RELATED TARIFF 87
TABLE 25 NORTH AMERICA: IMPACT OF US TARIFFS ON CANADA 88
TABLE 26 ASIA PACIFIC: IMPACT OF US TARIFFS ON CHINA, JAPAN, AND INDIA 88
TABLE 27 EUROPE: IMPACT OF US TARIFFS ON GERMANY AND UK 89
TABLE 28 LATIN AMERICA: IMPACT OF US TARIFFS ON MEXICO 89
TABLE 29 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: KEY PATENTS, 2023–2025 95
TABLE 30 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 103
TABLE 31 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 104
TABLE 32 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 105
TABLE 33 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 105
TABLE 34 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 106
TABLE 35 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF INTERVENTIONAL CARDIOLOGY DEVICES 110
TABLE 36 KEY BUYING CRITERIA FOR INTERVENTIONAL CARDIOLOGY DEVICES, BY END USER 111
TABLE 37 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: ADOPTION BARRIERS & INTERNAL CHALLENGES 112
TABLE 38 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 112
TABLE 39 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: KEY PROFITABILITY DRIVERS 114
TABLE 40 INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 116
TABLE 41 ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 117
TABLE 42 ANGIOPLASTY STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 117
TABLE 43 KEY PLAYERS PROVIDING DRUG-ELUTING STENTS 118
TABLE 44 DRUG-ELUTING STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 119
TABLE 45 DRUG-ELUTING STENTS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 120
TABLE 46 KEY PLAYERS PROVIDING BARE-METAL STENTS 121
TABLE 47 BARE-METAL STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 121
TABLE 48 BARE METAL STENTS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 122
TABLE 49 KEY PLAYERS PROVIDING BIOABSORBABLE STENTS 123
TABLE 50 BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 123
TABLE 51 BIOABSORBABLE STENTS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 124
TABLE 52 STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 126
TABLE 53 STRUCTURAL HEART DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127
TABLE 54 KEY PLAYERS PROVIDING AORTIC VALVE THERAPY DEVICES 128
TABLE 55 AORTIC VALVE THERAPY DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 129
TABLE 56 AORTIC VALVE THERAPY DEVICES MARKET, BY REGION,
2024–2031 (THOUSAND UNITS) 130
TABLE 57 KEY PLAYERS PROVIDING OTHER THERAPY DEVICES 130
TABLE 58 OTHER THERAPY DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 131
TABLE 59 OTHER THERAPY DEVICES MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 132
TABLE 60 CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 134
TABLE 61 CATHETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 135
TABLE 62 KEY PLAYERS PROVIDING ANGIOGRAPHY CATHETERS 136
TABLE 63 ANGIOGRAPHY CATHETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 137
TABLE 64 ANGIOGRAPHY CATHETERS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 138
TABLE 65 KEY PLAYERS PROVIDING GUIDING CATHETERS 139
TABLE 66 GUIDING CATHETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 139
TABLE 67 GUIDING CATHETERS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 140
TABLE 68 KEY PLAYERS PROVIDING IVUS/OCT CATHETERS 141
TABLE 69 IVUS/OCT CATHETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141
TABLE 70 IVUS/OCT CATHETERS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 142
TABLE 71 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 144
TABLE 72 ANGIOPLASTY BALLOONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145
TABLE 73 KEY PLAYERS PROVIDING OLD/NORMAL BALLOONS 146
TABLE 74 OLD/NORMAL ANGIOPLASTY BALLOONS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 147
TABLE 75 OLD/NORMAL BALLOONS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 148
TABLE 76 KEY PLAYERS PROVIDING DRUG-ELUTING BALLOONS 149
TABLE 77 DRUG-ELUTING BALLOONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 149
TABLE 78 DRUG-ELUTING BALLOONS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 150
TABLE 79 KEY PLAYERS PROVIDING CUTTING/SCORING BALLOONS 151
TABLE 80 CUTTING/SCORING BALLOONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 151
TABLE 81 CUTTING/SCORING BALLOONS MARKET, BY REGION,
2024–2031 (THOUSAND UNITS) 152
TABLE 82 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 154
TABLE 83 PLAQUE MODIFICATION DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 155
TABLE 84 KEY PLAYERS PROVIDING THROMBECTOMY DEVICES 156
TABLE 85 THROMBECTOMY DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 157
TABLE 86 THROMBECTOMY DEVICES MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 158
TABLE 87 KEY PLAYERS PROVIDING ATHERECTOMY DEVICES 159
TABLE 88 ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 159
TABLE 89 ATHERECTOMY DEVICES MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 160
TABLE 90 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 162
TABLE 91 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 163
TABLE 92 KEY PLAYERS PROVIDING EMBOLIC PROTECTION DEVICES 164
TABLE 93 EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 165
TABLE 94 EMBOLIC PROTECTION DEVICES MARKET, BY REGION,
2024–2031 (THOUSAND UNITS) 166
TABLE 95 KEY PLAYERS PROVIDING CHRONIC TOTAL OCCLUSION DEVICES 167
TABLE 96 CHRONIC TOTAL OCCLUSION DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 167
TABLE 97 CHRONIC TOTAL OCCLUSION DEVICES MARKET, BY REGION,
2024–2031 (THOUSAND UNITS) 168
TABLE 98 OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 170
TABLE 99 OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 171
TABLE 100 KEY PLAYERS PROVIDING GUIDEWIRES 172
TABLE 101 GUIDEWIRES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 173
TABLE 102 GUIDEWIRES MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 174
TABLE 103 KEY PLAYERS PROVIDING VASCULAR CLOSURE DEVICES 175
TABLE 104 VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 176
TABLE 105 VASCULAR CLOSURE DEVICES MARKET, BY REGION,
2024–2031 (THOUSAND UNITS) 177
TABLE 106 KEY PLAYERS PROVIDING INTRODUCER SHEATHS 178
TABLE 107 INTRODUCER SHEATHS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 178
TABLE 108 INTRODUCER SHEATHS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 179
TABLE 109 KEY PLAYERS PROVIDING BALLOON INFLATION DEVICES 180
TABLE 110 BALLOON INFLATION DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 180
TABLE 111 BALLOON INFLATION DEVICES MARKET, BY REGION,
2024–2031 (THOUSAND UNITS) 181
TABLE 112 KEY PLAYERS PROVIDING HEMOSTASIS HEART VALVES 181
TABLE 113 HEMOSTASIS HEART VALVES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 182
TABLE 114 HEMOSTASIS HEART VALVES MARKET, BY REGION,
2024–2031 (THOUSAND UNITS) 183
TABLE 115 INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 185
TABLE 116 INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION) 186
TABLE 117 INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 186
TABLE 118 INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR STANDALONE HOSPITAL FACILITIES, BY COUNTRY, 2024–2031 (USD MILLION) 187
TABLE 119 INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR LARGE CHAIN HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION) 188
TABLE 120 INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 190
TABLE 121 INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR CARDIAC CARE CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 191
TABLE 122 INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR OTHER END USERS,
BY COUNTRY, 2024–2031 (USD MILLION) 193
TABLE 123 INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 195
TABLE 124 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (THOUSAND UNITS) 198
TABLE 125 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 199
TABLE 126 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 199
TABLE 127 NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 199
TABLE 128 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 200
TABLE 129 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 200
TABLE 130 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 200
TABLE 131 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 201
TABLE 132 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 201
TABLE 133 NORTH AMERICA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 201
TABLE 134 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY END USER, 2024–2031 (USD MILLION) 202
TABLE 135 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 202
TABLE 136 US: MACROECONOMIC INDICATORS 203
TABLE 137 US: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 203
TABLE 138 US: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 204
TABLE 139 US: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 204
TABLE 140 US: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 204
TABLE 141 US: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 205
TABLE 142 US: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 205
TABLE 143 US: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 205
TABLE 144 US: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 206
TABLE 145 US: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 206
TABLE 146 US: INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 206
TABLE 147 CANADA: MACROECONOMIC INDICATORS 207
TABLE 148 CANADA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 208
TABLE 149 CANADA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 208
TABLE 150 CANADA: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 208
TABLE 151 CANADA: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 209
TABLE 152 CANADA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 209
TABLE 153 CANADA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 209
TABLE 154 CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 210
TABLE 155 CANADA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 210
TABLE 156 CANADA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 210
TABLE 157 CANADA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS,
BY TYPE, 2024–2031 (USD MILLION) 211
TABLE 158 EUROPE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE,
2024–2031 (THOUSAND UNITS) 212
TABLE 159 EUROPE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 213
TABLE 160 EUROPE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 213
TABLE 161 EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 214
TABLE 162 EUROPE: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 214
TABLE 163 EUROPE: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 214
TABLE 164 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 215
TABLE 165 EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 215
TABLE 166 EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 215
TABLE 167 EUROPE: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 216
TABLE 168 EUROPE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 216
TABLE 169 EUROPE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS,
BY TYPE, 2024–2031 (USD MILLION) 216
TABLE 170 GERMANY: MACROECONOMIC INDICATORS 217
TABLE 171 GERMANY: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 218
TABLE 172 GERMANY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 218
TABLE 173 GERMANY: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 218
TABLE 174 GERMANY: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 219
TABLE 175 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 219
TABLE 176 GERMANY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 219
TABLE 177 GERMANY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 220
TABLE 178 GERMANY: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 220
TABLE 179 GERMANY: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 220
TABLE 180 GERMANY: INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS,
BY TYPE, 2024–2031 (USD MILLION) 221
TABLE 181 FRANCE: MACROECONOMIC INDICATORS 222
TABLE 182 FRANCE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 222
TABLE 183 FRANCE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 222
TABLE 184 FRANCE: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 223
TABLE 185 FRANCE: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 223
TABLE 186 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 223
TABLE 187 FRANCE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 224
TABLE 188 FRANCE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 224
TABLE 189 FRANCE: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 224
TABLE 190 FRANCE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 225
TABLE 191 FRANCE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS,
BY TYPE, 2024–2031 (USD MILLION) 225
TABLE 192 UK: MACROECONOMIC INDICATORS 226
TABLE 193 UK: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 226
TABLE 194 UK: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 227
TABLE 195 UK: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 227
TABLE 196 UK: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 227
TABLE 197 UK: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 228
TABLE 198 UK: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 228
TABLE 199 UK: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 228
TABLE 200 UK: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 229
TABLE 201 UK: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 229
TABLE 202 UK: INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS,
BY TYPE, 2024–2031 (USD MILLION) 229
TABLE 203 ITALY: MACROECONOMIC INDICATORS 230
TABLE 204 ITALY: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 231
TABLE 205 ITALY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 231
TABLE 206 ITALY: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 231
TABLE 207 ITALY: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 232
TABLE 208 ITALY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 232
TABLE 209 ITALY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 232
TABLE 210 ITALY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 233
TABLE 211 ITALY: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 233
TABLE 212 ITALY: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 233
TABLE 213 ITALY: INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 234
TABLE 214 SPAIN: MACROECONOMIC INDICATORS 234
TABLE 215 SPAIN: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 235
TABLE 216 SPAIN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 235
TABLE 217 SPAIN: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 235
TABLE 218 SPAIN: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 236
TABLE 219 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 236
TABLE 220 SPAIN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 236
TABLE 221 SPAIN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 237
TABLE 222 SPAIN: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 237
TABLE 223 SPAIN: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 237
TABLE 224 SPAIN: INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS,
BY TYPE, 2024–2031 (USD MILLION) 238
TABLE 225 REST OF EUROPE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 238
TABLE 226 REST OF EUROPE; ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 239
TABLE 227 REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 239
TABLE 228 REST OF EUROPE: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 239
TABLE 229 REST OF EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 240
TABLE 230 REST OF EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 240
TABLE 231 REST OF EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 240
TABLE 232 REST OF EUROPE: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 241
TABLE 233 REST OF EUROPE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY END USER, 2024–2031 (USD MILLION) 241
TABLE 234 REST OF EUROPE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET
FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 241
TABLE 235 ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE,
2024–2031 (THOUSAND UNITS) 243
TABLE 236 ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 244
TABLE 237 ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 245
TABLE 238 ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 245
TABLE 239 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 245
TABLE 240 ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 246
TABLE 241 ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 246
TABLE 242 ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 246
TABLE 243 ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 247
TABLE 244 ASIA PACIFIC: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 247
TABLE 245 ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 247
TABLE 246 ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 248
TABLE 247 CHINA: MACROECONOMIC INDICATORS 248
TABLE 248 CHINA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 249
TABLE 249 CHINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 249
TABLE 250 CHINA: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 249
TABLE 251 CHINA: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 250
TABLE 252 CHINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 250
TABLE 253 CHINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 250
TABLE 254 CHINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 251
TABLE 255 CHINA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 251
TABLE 256 CHINA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 251
TABLE 257 CHINA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS,
BY TYPE, 2024–2031 (USD MILLION) 252
TABLE 258 JAPAN: MACROECONOMIC INDICATORS 252
TABLE 259 JAPAN: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 253
TABLE 260 JAPAN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 253
TABLE 261 JAPAN: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 253
TABLE 262 JAPAN CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 254
TABLE 263 JAPAN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 254
TABLE 264 JAPAN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 254
TABLE 265 JAPAN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 255
TABLE 266 JAPAN: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 255
TABLE 267 JAPAN: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 255
TABLE 268 JAPAN: INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS,
BY TYPE, 2024–2031 (USD MILLION) 256
TABLE 269 INDIA: MACROECONOMIC INDICATORS 256
TABLE 270 INDIA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 257
TABLE 271 INDIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 257
TABLE 272 INDIA: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 257
TABLE 273 INDIA: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 258
TABLE 274 INDIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 258
TABLE 275 INDIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 258
TABLE 276 INDIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 259
TABLE 277 INDIA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 259
TABLE 278 INDIA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 259
TABLE 279 INDIA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 260
TABLE 280 AUSTRALIA: MACROECONOMIC INDICATORS 260
TABLE 281 AUSTRALIA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 261
TABLE 282 AUSTRALIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 261
TABLE 283 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 261
TABLE 284 AUSTRALIA: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 262
TABLE 285 AUSTRALIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 262
TABLE 286 AUSTRALIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 262
TABLE 287 AUSTRALIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 263
TABLE 288 AUSTRALIA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 263
TABLE 289 AUSTRALIA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 263
TABLE 290 AUSTRALIA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS,
BY TYPE, 2024–2031 (USD MILLION) 264
TABLE 291 SOUTH KOREA: MACROECONOMIC INDICATORS 264
TABLE 292 SOUTH KOREA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 265
TABLE 293 SOUTH KOREA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 265
TABLE 294 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 265
TABLE 295 SOUTH KOREA: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 266
TABLE 296 SOUTH KOREA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 266
TABLE 297 SOUTH KOREA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 266
TABLE 298 SOUTH KOREA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 267
TABLE 299 SOUTH KOREA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 267
TABLE 300 SOUTH KOREA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 267
TABLE 301 SOUTH KOREA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 268
TABLE 302 REST OF ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 269
TABLE 303 REST OF ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 269
TABLE 304 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 270
TABLE 305 REST OF ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 270
TABLE 306 REST OF ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 270
TABLE 307 REST OF ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 271
TABLE 308 REST OF ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 271
TABLE 309 REST OF ASIA PACIFIC: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 271
TABLE 310 REST OF ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY END USER, 2024–2031 (USD MILLION) 272
TABLE 311 REST OF ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 272
TABLE 312 LATIN AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (THOUSAND UNITS) 273
TABLE 313 LATIN AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 274
TABLE 314 LATIN AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 274
TABLE 315 LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 275
TABLE 316 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 275
TABLE 317 LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 275
TABLE 318 LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 276
TABLE 319 LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 276
TABLE 320 LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 276
TABLE 321 LATIN AMERICA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 277
TABLE 322 LATIN AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY END USER, 2024–2031 (USD MILLION) 277
TABLE 323 LATIN AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 277
TABLE 324 BRAZIL: MACROECONOMIC INDICATORS 278
TABLE 325 BRAZIL: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 279
TABLE 326 BRAZIL: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 279
TABLE 327 BRAZIL: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 279
TABLE 328 BRAZIL: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 280
TABLE 329 BRAZIL: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 280
TABLE 330 BRAZIL: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 280
TABLE 331 BRAZIL: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 281
TABLE 332 BRAZIL: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 281
TABLE 333 BRAZIL: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 281
TABLE 334 BRAZIL: INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS,
BY TYPE, 2024–2031 (USD MILLION) 282
TABLE 335 MEXICO: MACROECONOMIC INDICATORS 282
TABLE 336 MEXICO: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 283
TABLE 337 MEXICO: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 283
TABLE 338 MEXICO: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 283
TABLE 339 MEXICO: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 284
TABLE 340 MEXICO: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 284
TABLE 341 MEXICO: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 284
TABLE 342 MEXICO: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 285
TABLE 343 MEXICO: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 285
TABLE 344 MEXICO: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 285
TABLE 345 MEXICO: INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS,
BY TYPE, 2024–2031 (USD MILLION) 286
TABLE 346 REST OF LATIN AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 286
TABLE 347 REST OF LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 287
TABLE 348 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 287
TABLE 349 REST OF LATIN AMERICA: CATHETERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 287
TABLE 350 REST OF LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 288
TABLE 351 REST OF LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 288
TABLE 352 REST OF LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 288
TABLE 353 REST OF LATIN AMERICA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 289
TABLE 354 REST OF LATIN AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY END USER, 2024–2031 (USD MILLION) 289
TABLE 355 REST OF LATIN AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET
FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 289
TABLE 356 MIDDLE EAST & AFRICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY TYPE, 2024–2031 (THOUSAND UNITS) 291
TABLE 357 MIDDLE EAST & AFRICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY REGION, 2024–2031 (USD MILLION) 292
TABLE 358 MIDDLE EAST & AFRICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 292
TABLE 359 MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 293
TABLE 360 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 293
TABLE 361 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 293
TABLE 362 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 294
TABLE 363 MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 294
TABLE 364 MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 294
TABLE 365 MIDDLE EAST & AFRICA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 295
TABLE 366 MIDDLE EAST & AFRICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY END USER, 2024–2031 (USD MILLION) 295
TABLE 367 MIDDLE EAST & AFRICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 295
TABLE 368 GCC COUNTRIES: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 296
TABLE 369 GCC COUNTRIES: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 297
TABLE 370 GCC COUNTRIES: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 297
TABLE 371 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 297
TABLE 372 GCC COUNTRIES: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 298
TABLE 373 GCC COUNTRIES: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 298
TABLE 374 GCC COUNTRIES: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 298
TABLE 375 GCC COUNTRIES: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 299
TABLE 376 GCC COUNTRIES: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 299
TABLE 377 GCC COUNTRIES: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 299
TABLE 378 GCC COUNTRIES: INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 300
TABLE 379 KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS 300
TABLE 380 KINGDOM OF SAUDI ARABIA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 301
TABLE 381 KINGDOM OF SAUDI ARABIA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 301
TABLE 382 KINGDOM OF SAUDI ARABIA: STRUCTURAL HEART DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 302
TABLE 383 KINGDOM OF SAUDI ARABIA: CATHETERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 302
TABLE 384 KINGDOM OF SAUDI ARABIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 302
TABLE 385 KINGDOM OF SAUDI ARABIA: PLAQUE MODIFICATION DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 303
TABLE 386 KINGDOM OF SAUDI ARABIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 303
TABLE 387 KINGDOM OF SAUDI ARABIA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 303
TABLE 388 KINGDOM OF SAUDI ARABIA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY END USER, 2024–2031 (USD MILLION) 304
TABLE 389 KINGDOM OF SAUDI ARABIA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 304
TABLE 390 UNITED ARAB EMIRATES: KEY MACROINDICATORS 305
TABLE 391 UNITED ARAB EMIRATES: INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 305
TABLE 392 UNITED ARAB EMIRATES: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 305
TABLE 393 UNITED ARAB EMIRATES: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 306
TABLE 394 UNITED ARAB EMIRATES: CATHETERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 306
TABLE 395 UNITED ARAB EMIRATES: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 306
TABLE 396 UNITED ARAB EMIRATES: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 307
TABLE 397 UNITED ARAB EMIRATES: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 307
TABLE 398 UNITED ARAB EMIRATES: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 307
TABLE 399 UNITED ARAB EMIRATES: INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY END USER, 2024–2031 (USD MILLION) 308
TABLE 400 UNITED ARAB EMIRATES: INTERVENTIONAL CARDIOLOGY DEVICES MARKET
FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 308
TABLE 401 OTHER GCC COUNTRIES: INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 309
TABLE 402 OTHER GCC COUNTRIES: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 309
TABLE 403 OTHER GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 310
TABLE 404 OTHER GCC COUNTRIES: CATHETERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 310
TABLE 405 OTHER GCC COUNTRIES: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 310
TABLE 406 OTHER GCC COUNTRIES: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 311
TABLE 407 OTHER GCC COUNTRIES: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 311
TABLE 408 OTHER GCC COUNTRIES: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 311
TABLE 409 OTHER GCC COUNTRIES: INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY END USER, 2024–2031 (USD MILLION) 312
TABLE 410 OTHER GCC COUNTRIES: INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 312
TABLE 411 REST OF MIDDLE EAST & AFRICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 313
TABLE 412 REST OF MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 313
TABLE 413 REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 313
TABLE 414 REST OF MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 314
TABLE 415 REST OF MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 314
TABLE 416 REST OF MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 314
TABLE 417 REST OF MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 315
TABLE 418 REST OF MIDDLE EAST & AFRICA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 315
TABLE 419 REST OF MIDDLE EAST & AFRICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 315
TABLE 420 REST OF MIDDLE EAST & AFRICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY HOSPITALS, 2024–2031 (USD MILLION) 316
TABLE 421 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES, JANUARY 2023–MAY 2026 318
TABLE 422 ANGIOPLASTY STENTS MARKET: DEGREE OF COMPETITION 321
TABLE 423 STRUCTURAL HEART DEVICES MARKET: DEGREE OF COMPETITION 322
TABLE 424 CATHETERS MARKET: DEGREE OF COMPETITION 323
TABLE 425 ANGIOPLASTY BALLOONS MARKET: DEGREE OF COMPETITION 324
TABLE 426 PLAQUE MODIFICATION DEVICES MARKET: DEGREE OF COMPETITION 325
TABLE 427 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET: DEGREE OF COMPETITION 326
TABLE 428 OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET: DEGREE OF COMPETITION 327
TABLE 429 REGION FOOTPRINT 333
TABLE 430 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: PRODUCT FOOTPRINT 334
TABLE 431 ANGIOPLASTY STENTS FOOTPRINT 335
TABLE 432 STRUCTURAL HEART DEVICES FOOTPRINT 336
TABLE 433 CATHETERS FOOTPRINT 337
TABLE 434 ANGIOPLASTY BALLOONS FOOTPRINT 338
TABLE 435 PLAQUE MODIFICATION DEVICES FOOTPRINT 339
TABLE 436 HEMODYNAMIC FLOW ALTERATION DEVICES FOOTPRINT 340
TABLE 437 OTHER INTERVENTIONAL CARDIOLOGY DEVICES FOOTPRINT 341
TABLE 438 END-USER FOOTPRINT 342
TABLE 439 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: DETAILED LIST OF
KEY START-UPS/SMES 345
TABLE 440 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 346
TABLE 441 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 349
TABLE 442 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: DEALS,
JANUARY 2023– MAY 2026 350
TABLE 443 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: EXPANSIONS,
JANUARY 2023–MAY 2026 351
TABLE 444 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW 352
TABLE 445 EDWARDS LIFESCIENCES CORPORATION: PRODUCTS OFFERED 353
TABLE 446 EDWARDS LIFESCIENCES CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 354
TABLE 447 EDWARDS LIFESCIENCES CORPORATION: DEALS, JANUARY 2023–MAY 2026 355
TABLE 448 ABBOTT: COMPANY OVERVIEW 357
TABLE 449 ABBOTT: PRODUCTS OFFERED 358
TABLE 450 ABBOTT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 361
TABLE 451 ABBOTT: DEALS, JANUARY 2023–MAY 2026 362
TABLE 452 MEDTRONIC: COMPANY OVERVIEW 364
TABLE 453 MEDTRONIC: PRODUCTS OFFERED 365
TABLE 454 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2023–MAY 2026 368
TABLE 455 MEDTRONIC: DEALS, JANUARY 2023–MAY 2026 369
TABLE 456 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 371
TABLE 457 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 372
TABLE 458 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2023–MAY 2026 377
TABLE 459 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2023–MAY 2026 378
TABLE 460 TERUMO CORPORATION: COMPANY OVERVIEW 380
TABLE 461 TERUMO CORPORATION: PRODUCTS OFFERED 381
TABLE 462 TERUMO CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026 385
TABLE 463 TERUMO CORPORATION: DEALS, JANUARY 2023–MAY 2026 386
TABLE 464 TERUMO CORPORATION.: EXPANSIONS, JANUARY 2023–MAY 2026 386
TABLE 465 TERUMO CORPORATION.: EXPANSIONS, JANUARY 2023–MAY 2026 387
TABLE 466 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 388
TABLE 467 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 389
TABLE 468 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2023–MAY 2026 390
TABLE 469 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023–MAY 2026 391
TABLE 470 CORDIS: COMPANY OVERVIEW 393
TABLE 471 CORDIS.: PRODUCTS OFFERED 393
TABLE 472 CORDIS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 395
TABLE 473 CORDIS: DEALS, JANUARY 2023–MAY 2026 395
TABLE 474 TELEFLEX INCORPORATED: COMPANY OVERVIEW 396
TABLE 475 TELEFLEX INCORPORATED: PRODUCTS OFFERED 397
TABLE 476 TELEFLEX INCORPORATED: PRODUCT APPROVALS, JANUARY 2023–MAY 2026 401
TABLE 477 TELEFLEX INCORPORATED.: DEALS, JANUARY 2023–MAY 2026 402
TABLE 478 ASAHI INTECC CO., LTD.: COMPANY OVERVIEW 403
TABLE 479 ASAHI INTECC CO., LTD.: PRODUCTS OFFERED 404
TABLE 480 ASAHI INTECC CO., LTD.: DEALS, JANUARY 2023–MAY 2026 407
TABLE 481 ASAHI INTECC CO., LTD: EXPANSIONS, JANUARY 2023–MAY 2026 408
TABLE 482 COOK: COMPANY OVERVIEW 409
TABLE 483 COOK: PRODUCTS OFFERED 409
TABLE 484 COOK: DEALS, JANUARY 2023–MAY 2026 411
TABLE 485 B. BRAUN SE: COMPANY OVERVIEW 412
TABLE 486 B. BRAUN SE: PRODUCTS OFFERED 413
TABLE 487 B. BRAUN SE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 417
TABLE 488 B. BRAUN SE: DEALS, JANUARY 2023–MAY 2026 417
TABLE 489 INTEGER HOLDINGS CORPORATION: COMPANY OVERVIEW 418
TABLE 490 INTEGER HOLDINGS CORPORATION: PRODUCTS OFFERED 419
TABLE 491 INTEGER HOLDINGS CORPORATION.: DEALS, JANUARY 2023–MAY 2026 420
TABLE 492 INTEGER HOLDINGS CORPORATION: EXPANSIONS, JANUARY 2023–MAY 2026 421
TABLE 493 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW 422
TABLE 494 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD: PRODUCTS OFFERED 423
TABLE 495 IVASCULAR S.L.U.: COMPANY OVERVIEW 426
TABLE 496 IVASCULAR S.L.U: PRODUCTS OFFERED 426
TABLE 497 BIOSENSORS INTERNATIONAL GROUP, LTD.: COMPANY OVERVIEW 428
TABLE 498 BIOSENSORS INTERNATIONAL GROUP, LTD.: PRODUCTS OFFERED 428
TABLE 499 STUDY ASSUMPTIONS 456
TABLE 500 RISK ASSESSMENT ANALYSIS 457
FIGURE 1 INTERVENTIONAL CARDIOLOGY DEVICES MARKET SEGMENTATION &
REGIONAL SCOPE 37
FIGURE 1 MARKET SCENARIO 41
FIGURE 2 GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET, 2024–2031 42
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN INTERVENTIONAL
CARDIOLOGY DEVICES MARKET, 2023–2025 43
FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF INTERVENTIONAL
CARDIOLOGY DEVICES MARKET 43
FIGURE 5 HIGH-GROWTH SEGMENTS IN INTERVENTIONAL CARDIOLOGY DEVICES MARKET, 2026–2031 44
FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN INTERVENTIONAL CARDIOLOGY DEVICES MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 45
FIGURE 7 STRONG FUTURE FOR MINIMALLY INVASIVE AND ADVANCED CARDIOVASCULAR INTERVENTIONS TO BOOST MARKET GROWTH 47
FIGURE 8 HOSPITALS AND CHINA DOMINATED MARKET IN 2025 48
FIGURE 9 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 49
FIGURE 10 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50
FIGURE 11 INTERVENTIONAL CARDIOLOGY DEVICES MARKET:
PORTER’S FIVE FORCES ANALYSIS 63
FIGURE 12 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: SUPPLY CHAIN ANALYSIS 67
FIGURE 13 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: VALUE CHAIN ANALYSIS 69
FIGURE 14 INTERVENTIONAL CARDIOLOGY DEVICES MARKET ECOSYSTEM 70
FIGURE 15 AVERAGE SELLING PRICE TREND OF STRUCTURAL HEART DEVICES, BY TYPE, 2023–2025 (USD) 75
FIGURE 16 AVERAGE SELLING PRICE OF ANGIOPLASTY STENTS, BY REGION, 2025 (USD) 77
FIGURE 17 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 83
FIGURE 18 INVESTMENT & FUNDING SCENARIO 84
FIGURE 19 TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR INTERVENTIONAL CARDIOLOGY DEVICE PATENTS, JANUARY 2015–MAY 2026 94
FIGURE 20 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: AI USE CASES 100
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF INTERVENTIONAL CARDIOLOGY DEVICES 109
FIGURE 22 KEY BUYING CRITERIA FOR INTERVENTIONAL CARDIOLOGY DEVICES, BY END USER 110
FIGURE 23 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET SNAPSHOT 197
FIGURE 24 ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET SNAPSHOT 243
FIGURE 25 REVENUE ANALYSIS OF KEY PLAYERS IN INTERVENTIONAL CARDIOLOGY DEVICES MARKET (2023−2025) 320
FIGURE 26 ANGIOPLASTY STENTS MARKET SHARE, BY KEY PLAYER, 2025 321
FIGURE 27 STRUCTURAL HEART DEVICES MARKET SHARE, BY KEY PLAYER, 2025 322
FIGURE 28 CATHETERS MARKET SHARE, BY KEY PLAYER, 2025 323
FIGURE 29 ANGIOPLASTY BALLOONS MARKET SHARE, BY KEY PLAYER, 2025 324
FIGURE 30 PLAQUE MODIFICATION DEVICES MARKET SHARE, BY KEY PLAYER, 2025 325
FIGURE 31 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET SHARE,
BY KEY PLAYER, 2025 326
FIGURE 32 OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET SHARE,
BY KEY PLAYER, 2025 327
FIGURE 33 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 330
FIGURE 34 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: COMPANY FOOTPRINT 331
FIGURE 35 INTERVENTIONAL CARDIOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 344
FIGURE 36 EV/EBITDA OF KEY VENDORS 347
FIGURE 37 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 347
FIGURE 38 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 348
FIGURE 39 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2025) 353
FIGURE 40 ABBOTT: COMPANY SNAPSHOT (2025) 358
FIGURE 41 MEDTRONIC: COMPANY SNAPSHOT (2025) 365
FIGURE 42 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2025) 372
FIGURE 43 TERUMO CORPORATION: COMPANY SNAPSHOT (2025) 381
FIGURE 44 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025) 389
FIGURE 45 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2025) 397
FIGURE 46 ASAHI INTECC CO., LTD.: COMPANY SNAPSHOT (2025) 404
FIGURE 47 B. BRAUN SE: COMPANY SNAPSHOT (2025) 413
FIGURE 48 INTEGER HOLDINGS CORPORATION: COMPANY SNAPSHOT (2025) 419
FIGURE 49 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY SNAPSHOT (2025) 423
FIGURE 50 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: RESEARCH DESIGN 439
FIGURE 51 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND
DEMAND-SIDE PARTICIPANTS 444
FIGURE 52 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 445
FIGURE 53 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 445
FIGURE 54 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 447
FIGURE 55 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 448
FIGURE 56 REVENUE SHARE ANALYSIS ILLUSTRATION: MEDTRONIC (2025) 449
FIGURE 57 TOP-DOWN APPROACH 450
FIGURE 58 BOTTOM-UP APPROACH 450
FIGURE 59 DEMAND-SIDE APPROACH 452
FIGURE 60 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF INTERVENTIONAL CARDIOLOGY DEVICES MARKET
(2026–2031) 453
FIGURE 61 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 454
FIGURE 62 DATA TRIANGULATION METHODOLOGY 455